【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Primary Research:
1.2.1 List of primary sources include
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Hyaluronic acid raw material Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Demographic shift in the U.S.
3.1.1.2 Growing demand for anti-aging solutions and minimally invasive aesthetic treatments
3.1.1.3 Growing usage of hyaluronic acid in cosmetic and medical field
3.1.2 Market restraint analysis
3.1.2.1 High costs and side effects associated with the use of hyaluronic acid
3.2 Key Opportunity Priorities
3.3 Hyaluronic Acid – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Hyaluronic acid raw material: Application Estimates & Trend Analysis
4.1 Hyaluronic Acid Market: Application Movement Analysis
4.2 Ophthalmology
4.2.1 Ophthalmology market revenue, 2013 – 2024 (USD Million)
4.2.2 Ophthalmology market volume, 2013 – 2024 (Thousand Kilograms)
4.2.3 Cataract surgery
4.2.3.1 Cataract surgery market revenue, 2013 – 2024 (USD Million)
4.2.3.2 Cataract surgery market volume, 2013 – 2024 (Thousand Kilograms)
4.2.4 Aqueous eye drop
4.2.4.1 Aqueous eye drop market revenue, 2013 – 2024 (USD Million)
4.2.4.2 Aqueous eye drop market volume, 2013 – 2024 (Thousand Kilograms)
4.2.5 Contact lens
4.2.5.1 Contact lens market revenue, 2013 – 2024 (USD Million)
4.2.5.2 Contact lens market volume, 2013 – 2024 (Thousand Kilograms)
4.3 Orthopedics
4.3.1 Orthopaedics market revenue, 2013 – 2024 (USD Million)
4.3.2 Orthopedics market volume, 2013 – 2024 (Thousand Kilograms)
4.3.3 Viscosupplements
4.3.3.1 Viscosupplements market revenue, 2013 – 2024 (USD Million)
4.3.3.2 Viscosupplements market volume, 2013 – 2024 (Thousand Kilograms)
4.3.4 Bone regeneration
4.3.4.1 Bone regeneration market revenue, 2013 – 2024 (USD Million)
4.3.4.2 Bone regeneration market volume, 2013 – 2024 (Thousand Kilograms)
4.4 Dermatology
4.4.1 Dermatology market revenue, 2013 – 2024 (USD Million)
4.4.2 Dermatology market volume, 2013 – 2024 (Thousand Kilograms)
4.4.3 Intradermal injections
4.4.3.1 Intradermal market revenue, 2013 – 2024 (USD Million)
4.4.3.2 Intradermal market volume, 2013 – 2024 (Thousand Kilograms)
4.4.4 Dermal fillers
4.4.4.1 Dermal fillers market revenue, 2013 – 2024 (USD Million)
4.4.4.2 Dermal filler market volume, 2013 – 2024 (Thousand Kilograms)
4.4.5 Wound healing
4.4.5.1 Wound healing market revenue, 2013 – 2024 (USD Million)
4.4.5.2 Wound healing market volume, 2013 – 2024 (Thousand Kilograms)
4.5 Drug Delivery
4.5.1 Drug delivery market revenue, 2013 – 2024 (USD Million)
4.5.2 Drug delivery market volume, 2013 – 2024 (Thousand Kilograms)
4.6 Medical Device Coating
4.6.1 Medical device coating market revenue, 2013 – 2024 (USD Million)
4.6.2 Medical device coating market volume, 2013 – 2024 (Thousand Kilograms)
4.7 Surgical Adhesion Prevention
4.7.1 Surgical adhesion prevention market revenue, 2013 – 2024 (USD Million)
4.7.2 Surgical adhesion prevention market volume, 2013 – 2024 (Thousand Kilograms)
4.8 Biomaterials and Implants
4.8.1 Biomaterial and implant market revenue, 2013 – 2024 (USD Million)
4.8.2 Biomaterial and implant market volume, 2013 – 2024 (Thousand Kilograms)
4.9 Cell and Tissue Preservation
4.9.1 Cell and tissue preservation market revenue, 2013 – 2024 (USD Million)
4.9.2 Cell and tissue preservation market volume, 2013 – 2024 (Thousand Kilograms)
Chapter 5 Hyaluronic acid raw material: Regional Estimates & Trend Analysis, by Application
5.1 Hyaluronic Acid Market Share, by Region, 2015 & 2024
5.2 North America
5.2.1 North America hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.2.2 North America hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.2.3 U.S
5.2.3.1 U.S. hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.2.3.2 U.S. hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.2.4 Canada
5.2.4.1 Canada hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.2.4.2 Canada hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.3 Europe
5.3.1 Europe hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.3.2 Europe hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.3.3 UK
5.3.3.1 UK hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.3.3.2 UK hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.3.4 Germany
5.3.4.1 Germany hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.3.4.2 Germany hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.4 Asia Pacific
5.4.1 Asia Pacific hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.4.2 Asia Pacific hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.4.3 Japan
5.4.3.1 Japan hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.4.3.2 Japan hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.4.4 China
5.4.4.1 China hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.4.4.2 China hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.5 Latin America
5.5.1 Latin America hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.5.2 Latin America hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.5.3 Brazil
5.5.3.1 Brazil hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.5.3.2 Brazil hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.5.4 Mexico
5.5.4.1 Mexico hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.5.4.2 Mexico hyaluronic acid market, 2013 – 2024 (Thousand Kilograms)
5.6 MEA
5.6.1 MEA hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.6.2 MEA hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.6.3 South Africa
5.6.3.1 South Africa hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.6.3.2 South Africa hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 Allergan
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 Sanofi
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic initiatives
6.1.3 Genzyme Corporation
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 Anika Therapeutics, Inc.
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic initiatives
6.1.5 Salix Pharmaceuticals
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Product benchmarking
6.1.5.4 Strategic initiatives
6.1.6 Seikagaku Corporation
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.3 Product benchmarking
6.1.7 F. Hoffmann-La Roche Ltd.
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Product benchmarking
6.1.7.4 Strategic initiatives
6.1.8 Galderma S.A.
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic initiatives
6.1.9 Zimmer Biomet
6.1.9.1 Company overview
6.1.9.2 Financial performance
6.1.9.3 Product benchmarking
6.1.10 Smith & Nephew
6.1.10.1 Company overview
6.1.10.2 Financial performance
6.1.10.3 Product benchmarking
6.1.10.4 Strategic initiatives
Chapter 7 Raw Material Suppliers Competitive Landscape
7.1 Company Profiles
7.1.1 Lifecore Biomedical
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic Initiatives
7.1.2 HTL Biotechnology
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.3 Shiseido
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 Bloomage Freda Biopharm Co. Ltd.
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 LG Life Sciences
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Maruha Nichiro, Inc.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 Contipro
7.1.7.1 Company Overview
7.1.7.2 Financial Performance
7.1.7.3 Product Benchmarking
7.1.7.4 Strategic Initiatives
7.1.8 Bio-Technology General
7.1.8.1 Company Overview
7.1.8.2 Financial Performance
7.1.8.3 Product Benchmarking
7.1.9 Teoxane Laboratories
7.1.9.1 Company Overview
7.1.9.2 Financial Performance
7.1.9.3 Product Benchmarking
7.1.9.4 Strategic Initiatives
7.1.10 QufuLiyangBiochem Industrial Co. Ltd
7.1.10.1 Company Overview
7.1.10.2 Financial Performance
7.1.10.3 Product Benchmarking
7.1.11 Cellbone Technology
7.1.11.1 Company Overview
7.1.11.2 Financial Performance
7.1.11.3 Product Benchmarking
7.1.12 Stanford Chemicals
7.1.12.1 Company Overview
7.1.12.2 Financial Performance
7.1.12.3 Product Benchmarking
7.1.13 Vesta Ingredients, Inc.
7.1.13.1 Company Overview
7.1.13.2 Financial Performance
7.1.13.3 Product Benchmarking
7.2 Hyaluronic Acid Raw Material Manufactures’ Market Share, 2015
【レポート販売概要】
■ タイトル：ヒアルロン酸（HA）原材料の世界市場分析：用途別（眼科、整形外科、皮膚科、薬品送達、医療機器コーティング、バイオマテリアル･インプラント、組織保存）、セグメント予測、2013 – 2024■ 英文：Hyaluronic Acid (HA) Raw Material Market Analysis By Application (Ophthalmology, Orthopedics, Dermatology, Drug Delivery, Medical Devices Coating, Biomaterials & Implants, Tissue Preservation), And Segment Forecasts, 2013 - 2024
■ 発行日：2017年3月29日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707411
■ 調査対象地域：グローバル
- 神経内分泌がん(Neuroendocrine Carcinoma)：世界の治験レビュー（2015年上半期版）Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2015" provides data on the Neuroendocrine Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuroendocrine Carcinoma. It includes an overview of the trial num …
- 化学療法誘発性好中球減少症治療薬の世界市場2018-2022About Chemotherapy-induced Neutropenia Therapeutics Neutrophils are immunity-inducing white blood cells. Reduction in its number causes neutropenia. Chemotherapy-induced neutropenia occurring during treatment increases patient’s risk of infection and disrupts cancer treatment. Technavio’s analysts forecast the Global Chemotherapy-Induced Neutropenia Therapeutics Market to grow at a CAGR of 5.52% d …
- スクラレオールの世界市場2015Sclareol (CAS 515-03-7) Market Research Report 2015 aims at providing comprehensive data on Sclareol market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Sclareol description, covers its application areas, manufacturing methods, patterns. It captures Sclareol market trends, pays close attention to Sclareol manufacturers and names suppliers. Besides, …
- A2A SpA：発電所及びSWOT分析2013A2A SpA - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and detailed in …
- アメリカのスマートフォン用音声認識市場Voice recognition is a type of authentication technology where sounds, words, or phrases spoken by humans are converted into electrical signals with assigned meanings. In this market research report, Technavio analysts estimate the voice recognition market in the US to surpass USD 601 million by 2019 owing to its augmented application in sending mails, messages, and we search. Growing popularity o …
- 心不全（心臓まひ）の疫学的予測EpiCast Report: Heart Failure - Epidemiology Forecast to 2025 Summary Heart Failure (HF), also referred to as congestive cardiac failure, is a heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic needs of the body. Eventually, without the heart's pumping action to deliver oxygen and nutrient-rich blood to the cells, fatigue, shortness of breath, a …
- 電気・電子産業におけるDM（デジタルマニュファクチャリング）の世界市場2017-2021About Digital Manufacturing DM is one of the emerging PLM solutions in the world. The adoption of DM allows the engineers to create a virtual environment of the manufacturing process starting from product definition to manufacturing. It creates digital models of tools, assembly lines, work centers, plant layout, and resources. DM provides simulation, visualization, analytics, and collaboration to …
- サイディングの世界市場予測（～2024年）“Increase in the infrastructural and construction activities are projected to drive the overall growth of the siding market across the globe from 2019 to 2024” The siding market is projected to grow from USD 72.9 billion in 2019 to USD 93.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 5.0% from 2019 to 2024. The global siding market has witnessed high growth primarily due to the inc …
- ゼオライト（沸石）の世界市場動向2014/2015The report presents a thorough study of zeolites, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing zeolites worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: zeolites production in the country, major manufac …
- 負荷監視システムの世界市場予測（～2024年）“Load monitoring system market to exhibit significant growth during 2018–2024”The load monitoring system market is estimated to grow from USD 2.6 billion in 2018 to USD 3.3 billion by 2024, at a CAGR of 4.0% during the forecast period. The key factors driving the growth of the market include rise in demand for load monitoring system in healthcare, increase in use of load monitoring system for test …
- 世界のeラーニング市場動向（2014～2018）TechNavio's analysts forecast the Global E-learning market to grow at a CAGR of 25.81 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing acceptance of E-learning among corporates. The Global E-learning market has also been witnessing the emergence of a new standard of HTML i.e., HTML5. However, the reluctance in accepting E-learning as an …
- Remicade（クローン病治療薬）：市場予測及び分析（～2022）Remicade (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety a …
- 2014年戦略提言：ヨーロッパの止血診断検査市場Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.SummaryThis comprehensive five-country report contains 500 pages, 120 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing market during the next five years. The report explores bu …
- 配電ユニットの世界市場予測（～2024年）“The power distribution unit market is projected to grow at a CAGR of 7.1% from 2019 to 2024” The power distribution unit market is projected to reach USD 5.2 billion by 2024 from an estimated USD 3.7 billion in 2019, at a CAGR of 7.1% during the forecast period. The rising concerns overpower stability for uninterrupted business operations, rising power distribution unit installations for reducing …
- Lime Disease：医療検査市場2014The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals …
